Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Nyxoah said its U.S. obstructive sleep apnea (OSA) device met all primary safety and efficacy endpoints in patients with complete concentric collapse (CCC) of the soft palate. The company is preparing a premarket approval supplement.
Nyxoah SA said its U.S. Pivotal Study met the primary safety and efficacy endpoints in complete concentric collapse patients.
NYXOAH said its ACCCESS U.S. pivotal study met primary safety and efficacy endpoints in complete concentric collapse patients.